Androgenetic Alopecia at Various Ages and Prostate Cancer Risk in an Equal-Access Multiethnic Case-Control Series of Veterans

March 2013 in “ Cancer Causes & Control ”

Jean-Alfred Thomas, Jodi Antonelli, Lionel L. Bañez, Cathrine Hoyo, Delores J. Grant, Wendy Demark-Wahnefried, Elizabeth A. Platz, Leah R. Gerber, Kathryn Shuler, Enwono Eyoh, Elizabeth Calloway, Stephen J. Freedland

androgenetic alopecia prostate cancer frontal balding high-grade disease androgenicity AA CaP

TLDR Early balding, especially frontal, increases prostate cancer risk; more research needed.

This study investigated the relationship between androgenetic alopecia (AA) and prostate cancer (CaP) risk in a multiethnic cohort of veterans. The results showed that earlier onset of balding, especially frontal balding, was associated with an increased risk of CaP diagnosis. AA, regardless of pattern, was linked with high-grade disease among men with CaP. However, the study relied on self-reported baldness to assess balding status from decades prior, which may underrepresent the true association between baldness and CaP risk. Further studies are required to assess to what degree age of AA onset and androgenicity may or may not jointly influence CaP development.

View this study on europepmc.org →

Discuss this study in the Community →

Research cited in this study

11 / 11 results

research Male Pattern Baldness and the Risk of Prostate Cancer

38 citations, February 2011 in “Annals of Oncology”

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

research Androgenic Alopecia Is Not Useful as an Indicator of Men at High Risk of Prostate Cancer

28 citations, June 2010 in “European Journal of Cancer”

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

research Male Pattern Baldness and Prostate Cancer Risk in a Population-Based Case-Control Study

29 citations, March 2010 in “Cancer epidemiology”

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

research Androgenetic Alopecia: Clinical Features, Classification, and Treatments

103 citations, June 2007 in “Endocrinology and Metabolism Clinics of North America”

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

research Hormonal Regulation of Hair Follicles Exhibits a Biological Paradox

98 citations, February 2007 in “Seminars in Cell & Developmental Biology”

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

research Psychological Effect, Pathophysiology, and Management of Androgenetic Alopecia in Men

112 citations, October 2005 in “Mayo Clinic Proceedings”

Minoxidil and finasteride can slow hair loss and stimulate regrowth, but won't restore all lost hair or reverse complete baldness.

research Validity of Self-Reported Male Balding Patterns in Epidemiological Studies

32 citations, December 2004 in “BMC Public Health”

Men can report their own balding patterns well enough for large health studies.

Follow-Up of 1 mg Finasteride Treatment of Male Pattern Baldness: Differences Between Clinical Trials and Private Office Follow-Up and Influences on Prescribing Habits Evaluated

research Follow-Up of 1 mg Finasteride Treatment of Male Pattern Baldness: Differences Between Clinical Trials and Private Office Follow-Up and Influences on Prescribing Habits Evaluated

6 citations, April 2004 in “Dermatologic Surgery”

Finasteride showed limited hair growth and low patient compliance in treating male pattern baldness.

research Androgenetic Alopecia: Pathogenesis and Potential for Therapy

174 citations, November 2002 in “Expert Reviews in Molecular Medicine”

Hair loss needs more research for better treatments.

research Vertex Balding, Plasma Insulin-Like Growth Factor 1, and Insulin-Like Growth Factor Binding Protein 3

26 citations, June 2000 in “Journal of The American Academy of Dermatology”

Men with balding at age 45 had higher IGF-1 and lower IGFBP-3, suggesting these factors might be important in male pattern baldness.

research Association of Benign Prostatic Hyperplasia with Male Pattern Baldness

54 citations, May 1998 in “Urology”

Men with enlarged prostates often have more severe baldness.

Similar Research

5 / 1000+ results

research Male Pattern Baldness and Risk of Colorectal Neoplasia

7 citations, January 2016 in “British Journal of Cancer”

Men with certain types of baldness at age 45 may have a higher risk of colon cancer and colorectal adenoma.

research Antiandrogens and Androgen Inhibitors in Dermatologic Treatments

November 2020 in “Elsevier eBooks”

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

research Dermatologic Manifestations of Polycystic Ovary Syndrome

76 citations, January 2007 in “American Journal of Clinical Dermatology”

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

research Androgens and Human Hair Growth

157 citations, April 1994 in “Clinical endocrinology”

Androgens can cause hair growth in some areas and hair loss on the scalp.

research Diagnosis and Management of the Dermatologic Manifestations of Polycystic Ovary Syndrome

97 citations, July 2006 in “Dermatologic therapy”

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.